SPC436
Neratíníb
Status:
UmsóknApplication date:
11.7.2023Application published:
15.8.2023
Max expiry date:
30.8.2033Medicine name:
NerlynxMedicine for children:
No
Timeline
Today
11.7.2023Application
15.8.2023Publication
30.8.2033Expires
Marketing license
Date:
26.9.2018
Foreign authorization number:
EU/1/18/1311Date:
31.8.2018
Owner
Name:
Wyeth LLCAddress:
66 Hudson Boulevard East, New York, NY 10001-2192 US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113 Reykjavík
Patent
Number:
EP3000467